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ABSTRACT The objective of the current study was to
identify QTL conferring resistance to Marek’s disease
(MD) in commercial layer chickens. To generate the re-
source population, 2 partially inbred lines that differed
in MD-caused mortality were intermated to produce 5
backcross families. Vaccinated chicks were challenged
with very virulent plus (vv+) MD virus strain 648A at 6
d and monitored for MD symptoms. A recent field isolate
of the MD virus was used because the lines were resistant
to commonly used older laboratory strains. Selective gen-
otyping was employed using 81 microsatellites selected
based on prior results with selective DNA pooling. Linear
(Key words: chicken, Marek’s disease, quantitative trait loci, survival, genetic resistance)
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INTRODUCTION
Marek’s disease (MD), a lymphoma caused by an avian
herpesvirus, is a major disease affecting the poultry in-
dustry. It has been roughly estimated that, worldwide,
Marek’s disease costs the poultry industry $1 billion to
$2 billion a year (Morrow and Fehler, 2004). The economic
damage of MD is probably even greater because immuno-
suppression induced by the MD virus reduces resistance
to other pathogens, which can lead to symptoms in young,
market-weight broilers (Biggs et al., 1968; Abbassi et al.,
1999), and lowers feed efficiency and other production
traits (Groves, 1995; Islam et al., 2002). Vaccines have
been produced that initially were effective in reducing
MD incidence (Witter, 1985), but MD virus strains have
evolved to the point that commercial vaccines are no
longer fully protective.
An alternative method to reduce the incidence of MD
is to genetically improve the chicken’s innate resistance
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regression and Cox proportional hazard models were
used to detect associations between marker genotypes
and survival. Significance thresholds were validated by
simulation. Seven and 6 markers were significant based
on proportion of false positive and false discovery rate
thresholds less than 0.2, respectively. Seventeen markers
were associated with MD survival considering a compari-
son-wise error rate of 0.10, which is about twice the num-
ber expected by chance, indicating that at least some of
the associations represent true effects. Thus, the present
study shows that loci affecting MD resistance can be
mapped in commercial layer lines. More comprehensive
studies are under way to confirm and extend these results.
to this disease. Resistance or susceptibility to MD is a
quantitative trait that is affected by multiple genes and
the environment. Genetic improvement of quantitative
traits can be achieved by selection of individuals with
favorable phenotypic characteristics, by marker-assisted
selection on genomic regions that harbor genes that confer
the favorable phenotype, or both (Lande and Thompson,
1990). Marker-assisted selection is particularly useful for
traits of low heritability and those that are sex-limited or
difficult to measure. The MD resistance falls into all of
these categories.
Use of marker-assisted selection requires knowledge
of genes affecting a trait or of markers tightly linked to
those genes (Dekkers and Hospital, 2002). A genome scan
can be used to identify regions of the genome that harbor
genes affecting a quantitative trait of interest, so-called
QTL (Soller and Beckmann, 1983; Beckmann and Soller,
1983). Once a QTL region is identified, it can be more
intensely studied to find the causative gene or a closely
linked marker for use in selection programs.
Genomic regions associated with resistance to MD have
been identified in several studies of noncommercial poul-
try populations. Vallejo et al. (1998) and Yonash et al.
(1999) identified QTL on chromosomes 1, 2, 4, 7, and 8
that affect MD resistance; they used the same F2 cross
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between 2 White Leghorn lines (Avian Disease and Oncol-
ogy Laboratory lines 6 and 7; ADOL) that differed in MD
resistance. Bumstead (1998) used a backcross of the same
ADOL lines to map a QTL for MD resistance on chromo-
some 1. Many studies have shown that the MHC complex
(B blood group) on chromosome 16 affects resistance to
MD (Hanson et al., 1967; Bacon et al., 1981; Bacon, 1987;
Schierman and Collins, 1987; Lamont, 1989; Bacon and
Witter, 1994; Schat et al., 1994). The growth hormone gene
(GH1) on chromosome 1 also has an allelic association
with MD resistance (Kuhnlein et al., 1997; Liu et al.,
2001b). Microarray analysis has shown that GH1 expres-
sion is associated with differences in MD resistance (Liu
et al., 2001a) and the GH1 protein has been shown to
interact with the SORF2 protein, a protein only found in
virulent MD virus strains (Liu et al., 2001b). Stem lympho-
cyte antigen 6 complex locus E (LY6E) on chromosome 2
has also been identified as an MD resistance gene through
genetic, RNA, and protein analysis (Liu et al., 2003). Be-
cause all of these studies used experimental populations,
it is important to confirm the association of these QTL
regions with MD in commercial populations, which will
enable selection upon the QTL in those populations. The
objective of the current study, therefore, was to identify
QTL associated with MD resistance (defined as survival
time following challenge) in a cross between lines of com-
mercial layer chickens.
MATERIALS AND METHODS
Experimental Population and Phenotyping
The population was a backcross between 2 partially
inbred lines (as determined by foundation from narrow
genetic bases) of commercial layer chickens. In a prior
screening of the parental lines for 102 microsatellite mark-
ers, 60% were fixed in line 1 and 80% in line 2. The lines
were also fixed for different serologically typed B blood
group alleles: B2 in line 1 and B15 in line 2. Prior studies
also have shown the parental lines to differ in susceptibil-
ity to experimental challenge with a very virulent MD
virus; the percentage of MD mortality was 41.4 and 21.0
percentage points higher in line 1 than line 2 in 2 separate
experiments (data not shown), defining line 2 as the more
resistant of these 2 lines.
To produce the resource population (see Figure 1), 5
males from line 1 were pair mated to individual line 2
females to generate 5 full-sib F1 families. Seven males
from each F1 family were each mated to 15 females from
line 1 to generate 5 grandsire backcross groups, each
consisting of 7 half-sib sire families.
A total of 656 backcross female chicks (85 to 160 per
backcross group) were vaccinated with 500 plaque-form-
ing units of bivalent HVT/SB-1 vaccine (Merial Select,
Gainesville, GA) at 1 d of age and subcutaneously inocu-
lated with 500 plaque-forming units of the very virulent
plus (vv+) 648A MD virus strain (Witter, 1997) at 6 d of
age. Age at death and presence or absence of tumors by
visual examination was recorded from 30 to 140 d of age.
Initiation of records at 30 d of age excludes typical early
chick and brooding mortality. Birds surviving to the end
of the study (140 d) were euthanized by CO2 inhalation.
Treatment of the birds met or exceeded accepted guide-
lines (ADSA, 1988). Birds were housed and phenotypic
data were collected at Hy-Line International (Dallas Cen-
ter, IA). Survival time, quantified based on number of
days of survival after experimental challenge with a viru-
lent MD virus, was the phenotype used for QTL mapping.
Markers and Genotyping
For DNA isolation, blood was collected from the jugu-
lar vein at 3 wk of age in syringes containing EDTA with
22-gauge needles. A Qiagen QIAamp DNA Blood Mini
kit (Qiagen, Valencia, CA) was used for DNA isolation
according to the manufacturer’s instructions, except that
25 uL of whole blood plus 175 uL of PBS were used for
the spin protocol, and the samples were incubated at 70°C.
The backcross progeny were selectively genotyped
(Lander and Botstein, 1989; Darvasi and Soller, 1992) by
genotyping the 20% (n = 133) of chicks with shortest
survival times past 30 d and that had tumors and the
20% that were the longest survivors (n = 134) for 81 micro-
satellite markers. Individuals in the extremes of the phe-
notypic distribution contain the majority of information
needed to identify markers linked to that trait (Lander
and Botstein, 1989), which maximizes power with limited
genotyping (Lebowitz et al., 1987). The presence of macro-
scopically visible tumors was used as a defining trait
to place short-surviving birds into the category of MD-
susceptible short survivors, thus minimizing the place-
ment into this category of birds that died from causes
that were not related to MD. All paternal grandparents
and F1 sires were also genotyped, but genotypes were
not available for dams of the backcross chicks.
Markers used in the current study were chosen based
on their associations with MD resistance in 2 preliminary
selective DNA pooling analyses (unpublished data), fol-
lowing methods described in Darvasi and Soller (1994)
and Lipkin et al. (1998). Fifty-six of the 81 genotyped
markers were chosen based on a selective DNA pooling
analysis of 117 markers in this population (data not
shown), and the 25 additional markers were chosen from
120 tested markers based on a selective DNA pooling
analysis of the reciprocal backcross population (data not
shown). Markers that were included in the initial pooling
analyses were chosen by position to get maximal genomic
coverage. The 81 markers were distributed among 17
chromosomes; 16 were on chromosome 1, 14 on 2, 10 on
3, 9 on Z, 8 on 5, 7 on 4, 4 on 15, 2 each on 6, 8, and 18,
and 1 each on 7, 9, 13, 17, 23, 27, and E22. The average
marker interval for chromosomes with multiple markers
was 37 cM.
Statistical Analyses
Line Origin Probabilities. The objective of the statisti-
cal analyses was to identify associations of marker alleles
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Figure 1. Population design used to generate each of the 5 grandparental backcross families. Numbers of individuals are indicated by the
numbers in the circles. Five line 1 males were pair-mated to 5 line 2 females to generate 5 full-sib F1 families. Seven sires from each of the 5 F1
families were each mated to approximately 15 line 1 females to generate 5 groups (by grandsire) of backcross individuals. Length of survival was
recorded for all backcross individuals. Genotypes for 81 microsatellite markers were known for all grandparents, F1 sires, and selected backcross
individuals. Genotypes were not observed for the dams of the backcross individuals. MD = Marek’s disease.
with survival in the backcross offspring, based on line
origin of the marker allele that was inherited from the F1
sire. Line origin could be determined for 38 markers that
were fixed for alternative alleles in the parental lines and
for 23 markers for which distinct alleles were segregating
in the parental lines. For 20 of the 81 markers, however,
parental lines segregated at least one common allele. For
such markers, an offspring was not fully informative
when identically heterozygous to the F1 sire. On average
across these markers, 55% of the offspring were not fully
informative. Although genotypes of the backcross dams
were unknown, allelic frequencies in the line were known
from previous genotyping of individuals from line 1.
These frequencies were used to infer the probability that
a dam transmitted a given allele to the noninformative
offspring and, equivalently, the probability that the sire
transmitted the alternate allele. The probability that a
backcross offspring with marker genotype A1A2 inherited
a line 1 allele from its F1 sire (p(L1)) was then computed as
p(L1) = p(A1 = L1| A1 = F1) p(A1 = F1) + p(A2
= L1| A2 = F1) p(A2 = F1)
where p(Aj = L1| Aj = F1) is the probability that allele Aj
originated from line 1 given that it came from the F1 sire
(= 1, 0.5, or 0 following Mendelian inheritance) and can
be computed based on allele frequencies among dams,
f(Aj), as
p(Aj = F1) = 1 − f(Aj) / [f(A1) + f(A2)].
Note that because p(L1) = 1 − p(L2), all information on
line origin is captured by p(L1).
Statistical Models. Only individuals that were geno-
typed were included in the analyses. The phenotypic data
were right-skewed and censored (some individuals sur-
vived to the end of the study and therefore did not have
a date of death), and only phenotypic extremes were
genotyped (selective genotyping). For this reason the Cox
proportional hazards (CPH) model (Cox, 1972) was used
for analysis, in addition to regular least squares regression
(Legendre, 1805). Aside from the proportional hazards
assumption, estimation for the CPH model is rank based
(distribution free) and accommodates survival data with
censoring (Smith, 2002); therefore, it may be more appro-
priate than least squares regression for analysis of these
data. Effect estimates from the CPH model can be inter-
preted as natural logarithms of ratios of hazards. The least
squares regression model was also considered because it
is computationally easier to use than the CPH model, and
the effect estimates from linear regression have a more
convenient interpretation with respect to mean survival
time.
In preliminary analyses under the CPH model, effects
of grandsire, blood group genotype, their interaction, and
the interactions of these effects with p(L1) did not occur
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more often than expected by chance, considering a com-
parison-wise error rate (CWER) of 0.05 (fewer than 5%
of the tests had a CWER = 0.05 for each of the effects).
Therefore, these effects were not included in the final
models for analysis.
The final model used for linear regression analysis was
Si = βp(L1)i + εi
where Si is the survival time of animal i, in days; β is
the increase in the mean survival time associated with
inheriting the line 1 versus the line 2 marker allele; p(L1)i
is as defined previously for animal i; and εi is the residual
for animal i.
In accordance with Smith (2002), the model used for
CPH analysis was
S(t;ηi) = [S0(t)]exp(ηi)
where S(t;ηi) is the probability that animal i survived at
least until time t, and S0(t) is the baseline survivor
function:
S0(t) = e∫ h0(t)dt
where h0(t) is the baseline hazard function and
ηi = βp(L1)i.
The corresponding hazard function is
h(t) = exp(ηi)h0(t) = exp(βp(L1)i)h0(t),
where β is the allelic effect on the natural log of the ratio
of hazards for inheriting the line 1 versus line 2 marker,
and p(L1)i is as defined previously. This formulation of
the model allows the use of standard CPH statistical soft-
ware for estimation of β, and the baseline hazard is not
needed to estimate β (Smith, 2002). This approach pro-
vides an approximation to a partial likelihood estimator
for β, as discussed in the appendix of this paper. Simula-
tion of data under the null hypothesis of no QTL effect
was used to ensure that the standard probability values
that were obtained from each model were appropriate.
To account for multiple testing, the false discovery rate
(FDR; Benjamini and Hochberg, 1995; Weller et al., 1998)
and the probability of false positives (PFP; Fernando et al.,
2004; Heifetz, 2004) statistics were used as an indication of
the strength of associations of markers with survival.
The linear regression and CPH models were compared
based on their abilities to identify markers associated with
MD survival and for their agreement in comparison-wise
probability values and estimates of marker effects. The β
coefficient in the linear regression model is interpreted
in units of days, whereas β in the CPH model is interpre-
ted in terms of the conditional odds of dying during a
short period of time after any particular time point given
that an animal survives up to that time point. Because of
their different scales, a correlation was used to compare
the effect estimates and probability values of the 2 models.
Simulation Analysis. To determine whether standard
probability values were appropriate for the analyses that
were conducted, survival data with properties similar to
the observed data were simulated with a backcross model
under the null hypothesis of no QTL, following proce-
dures described by Vincent Ducrocq (Station de Gen-
etique Quantitative et Appliquee, Institut National de la
Recherche Agronomique, France, personal communica-
tion). To simulate new samples of survival times that
reflect the features of the observed data, a survival func-
tion (S(t)) was estimated from the observed data using
the nonparametric Kaplan-Meier estimator (Kaplan and
Meier, 1958) of a survivor function:
Sˆ(t) = Π
k
j=1
nj − dj
nj
for t(k) ≤ t < t(k+1), where j is the rank of a particular day
(t) among all chronologically ordered days in which death
occurred, k is the rank of the day at which the survival
function is being evaluated, nj is the number of animals
at risk on day j, and dj is the number of birds dying on
day j. Note that nj excludes any birds that died or were
censored before day j, but includes any bird censored at
day j. Sˆ(t) = 1 for 0 ≤ t < t(1). In this application birds were
only censored at 140 d. A simulated sample of death times
was obtained by drawing a sample from a uniform [0,1]
distribution and inverting the Kaplan-Meier estimate of
the survivor function to obtain death times. Birds with
death times exceeding 140 d were censored at 140 d. Each
bird was also independently assigned 1 of 2 marker alleles
based on a random draw from a binomial distribution
with a 50% chance of inheriting either allele, simulating
a marker linked to a QTL with no effect. To simulate
selective genotyping data, the simulated birds were
ranked based on survival time, and the 20% shortest and
longest survivors were analyzed using the linear regres-
sion and CPH models. Birds surviving to 140 d were
considered censored for the CPH model and as dying at
140 d for the linear regression model. This process was
repeated for 1,000 replicates of 700 birds, and the propor-
tions of replicates with a probability value less than
CWER levels of 0.1, 0.05, 0.01, and 0.001 were compared
with the expected false positive rate for those levels. A
2-tailed binomial test (Miller and Miller, 1999) was used
to identify deviations from expectations.
RESULTS
Distribution of Survival Times
Survival times in the backcross population over the
recording time (30 to 140 d) ranged from 33 to 140 d
(Figure 2). Survival times followed a right-skewed distri-
bution with a mean of 65.5 d, a median of 59.0 d, and a
standard deviation of 23.9 d. Twenty-eight individuals
 at Iow
a State U
niversity on N
ovem
ber 12, 2015
http://ps.oxfordjournals.org/
D
ow
nloaded from
 
MCELROY ET AL.1682
Figure 2. Distribution of length of survival in the backcross popula-
tion. Dark shading indicates the selectively genotyped individuals.
(4.3%) survived to the end of the study and were consid-
ered censored in the analyses.
False Positive Rates
Table 1 shows the percentage (of 1,000 simulated repli-
cates) of tests that had a comparison-wise probability
value less than 0.1, 0.05, 0.01, or 0.001 from analyzing the
selective genotyping survival data simulated under the
null hypothesis (no QTL effect) with the linear regression
and CPH models. None of the false positive rates were
significantly different (P = 0.05) from the expected rates
(the four CWER thresholds) based on a 2-tailed binomial
test. This finding indicates that the comparison-wise
probability values obtained from the actual data corre-
spond to tests with valid type I error levels for both
methods of analysis.
Marker Analysis
As mentioned above, in preliminary analyses, propor-
tions of significant effects of grandsire and blood group
did not deviate from the expected by chance using a
CWER of 0.05 under the CPH model and, therefore, they
were not included in the final models for analysis. Our
results, summarized in Table 2 and Figure 3, show 7 and
6 markers that exceeded a 0.2 threshold using PFP and
FDR, respectively. Results for an additional 10 markers,
Table 1. False positive rates for the linear regression and Cox’s propor-
tional hazards models from simulation under the null hypothesis of no
QTL effect, for different comparison-wise significance levels1
Comparison-wise significance level2
Model 0.1 0.05 0.01 0.001
Linear regression 0.111 0.053 0.01 0
Cox proportional hazard 0.108 0.066 0.007 0
1Results are based on 1,000 replicates.
2With a 2-tailed binomial test, none of the values were different (com-
parison-wise P ≤ 0.05) from the expected values based on significance
level.
which were significant relative to a CWER of 0.10 but
did not reach a PFP of FDR threshold of 0.2, are also
summarized in Table 2 and Figure 3. Although the evi-
dence of an association of these markers with survival is
not as strong, these results are included here so that they
can be compared with results from other experiments
that are or will be reported in the literature and so that
trends can be observed in identified genomic regions re-
ported in the present study. The corresponding locations
from the consensus genetic linkage map of the chicken
are also indicated in Table 2 and Figure 3.
Correlations of Effect Estimates
and Probability Values
The correlation between effect estimates from the linear
regression and CPH analyses of all markers was −0.96,
indicating that CPH estimates can be accurately predicted
from linear regression estimates. The negative relation-
ship arises from the difference in the interpretation of the
parameters in the 2 models; a shorter expected survival
time from the regression model corresponds to a larger
hazard ratio in the CPH model. The correlation between
the probability values from the 2 models was 0.83, sug-
gesting good correspondence in the degree of sig-
nificance.
DISCUSSION
Comparison of Analyses
Analysis of the simulated selective genotyping survival
data showed that standard determinations of CWER re-
sulted in valid false positive rates and, therefore, in valid
probability values for the CPH and linear regression mod-
els. This result was expected for the CPH model because,
assuming the proportional hazards assumption was met,
the data did not violate assumptions of the model. This
result was not necessarily expected for linear regression
because the assumption of normally distributed data was
violated (Larsen and Marx, 1990). The CWER for the lin-
ear regression analysis appeared robust to violation of
this assumption, likely because the numbers of individu-
als were large enough for the central limit theorem to
become a factor (Miller and Miller, 1999). The estimated
coefficients, therefore, had a large sample normal distri-
bution, and so the significance tests also had an approxi-
mate normal distribution. This finding does not, however,
mean that the effect estimates obtained from either of
these models are valid. Linear regression overestimates
QTL effects when selective genotyping is used, even if
phenotype is normally distributed in the complete data
set (Lander and Botstein, 1989). Darvasi and Soller (1992)
and Ronin et al. (1998) proposed methods to correct this
bias for normally distributed traits, but these methods
are not appropriate for survival data because of skewness
and censoring.
From analysis of the actual data, linear regression ap-
pears to be as, or more, powerful than the CPH model
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Table 2. Markers associated (comparison-wise P ≤ 0.10) with Marek’s disease survival
Linear regression Cox’s proportional hazards
Marker Chromosome Position1 P-value Effect (d)2 P-value Effect2
ADL0309 2 90 0.0143,4 −10.71 0.051 0.26
ADL0176 2 115 0.0113,4 −12.01 0.0063,4 0.40
ADL0300 2 225 0.074 −7.65 0.191 0.17
MCW0034 2 230 0.086 −7.79 0.232 0.17
MAXL 45 220 0.031 9.28 0.124 −0.20
LEI0116 5 5 0.0183 10.32 0.067 −0.25
ADL0253 5 45 0.0073,4 20.01 0.0083,4 −0.64
ADL0023 5 100 0.081 7.53 0.135 −0.20
HUJ0005 6 40 0.094 7.24 0.161 −0.19
ADL0278 8 95 0.161 −6.00 0.083 0.23
MCW0231 15 30 0.029 −16.13 0.057 0.42
ADL0022 Z 0 0.0013,4 −14.63 0.0013,4 0.46
MCW0331 Z 20 0.0003,4 −15.27 0.0013,4 0.45
MCW0055 Z 30 0.0013,4 −14.54 0.0013,4 0.44
MCW0258 Z 35 0.092 −7.22 0.066 0.24
ADL0273 Z 75 0.076 −7.61 0.049 0.26
LEI0121 Z 130 0.103 −7.00 0.077 0.23
1Locations from the consensus genetic linkage map of the chicken (Groenen et al., 2000; Schmid et al., 2000).
2Negative effects from the linear regression model (in days) and positive effects from the Cox proportional
hazards (in terms of the effect on the natural log of the hazard ratio) model indicate that the favorable allele
was derived from the more resistant line.
3Significant based on the proportion of false positive rate ≤ 0.2 [equivalent comparison-wise significance levels:
0.0183 (linear regression) and 0.008 (Cox proportional hazards)].
4Significant based on false discovery rate ≤ 0.2 [equivalent comparison-wise significance levels: 0.0143 (linear
regression) and 0.008 (Cox proportional hazards)].
5There is evidence that MAXL may not be on chromosome 4 (Wang, 2003).
for analyzing the selective genotyping survival data.
There was a strong linear relationship between estimates
from the 2 models. An advantage of the linear regression
model over the CPH model is that estimated coefficients
are much easier to interpret. Estimates from linear regres-
sion are in days of survival, whereas CPH estimates are
in terms of an exponential function of the odds that ani-
mals die within a short period of time following some
time point given that the animals survive up to that time
point. Estimation of coefficients in the CPH model is a
based on the ranks of the death and censoring times,
which results in the model ignoring information in the
spacing between death times. The regression approach
uses information in the spacing of death times, but it will
be affected by the handling of censoring times. Use of
the censoring time as a death time in the regression analy-
sis was not a major issue in the current study because
censoring only occurred at 140 d, and only 4.3% of the
birds survived beyond 140 d.
Markers Associated
with Marek’s Disease Survival
Several markers were associated with length of survival
in this postvaccination MD challenge using an FDR or
PFP threshold of 0.2. One of these markers corresponds
to a QTL identified on chromosome 2 near the region
identified for MD susceptibility by Yonash et al. (1999)
and Vallejo et al. (1998) (around 90 cM on the consensus
map). Confirmation of QTL in multiple populations is
important for eliminating false positives and demonstra-
ting segregation of the QTL in multiple populations. In
the current study, no QTL were found in regions on chro-
mosomes 1, 4, 7, 8, 12, and 17, which were identified as
possibly harboring QTL by Vallejo et al. (1998), Yonash
et al. (1999), and Bumstead (1998). These discrepancies
could be due to lack of segregation of these same QTL
between the lines used in the present study, insufficient
power, or false positives in the other 3 studies. Discrepan-
cies between the studies might also have arisen because
a recent vv+ field isolate of the MD virus was used in
the current study, whereas the other studies used less
virulent strains. The lines of birds used here are resistant
to the commonly used older laboratory strains of the MD
virus. Previous studies also did not identify the strong
QTL identified in the present study on chromosome Z.
This may be due to the fact that in the previous studies,
this chromosome was only surveyed with a single marker.
In an F2 cross of highly inbred chicken lines, however,
Zhou et al. (2003) identified a QTL for antibody response
kinetics on chromosome Z, near the QTL for MD resis-
tance identified in the present study. The growth hormone
receptor gene is also located on chromosome Z near the
same position. The GH1 gene (on chromosome 1) has
been associated in previous studies with MD resistance
(Kuhnlein et al., 1997; Liu et al., 2001a,b). Interactions
between markers near the GH1 and the growth hormone
receptor genes affecting MD resistance were not signifi-
cant (data not shown).
For the 17 markers identified in the present study to
have an association with MD resistance with a CWER ≤
0.10, 12 showed allele effects in the expected direction,
and the favorable allele originated from the more resistant
line 2. These QTL, therefore, explain part of the difference
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MCELROY ET AL.1684
Figure 3. Markers associated with Marek’s disease resistance (comparison-wise P ≤ 0.1) on chromosomes 2, 5, and Z. Markers are indicated on
the right side of each chromosome and their positions (cM) on the left. The stringency of the threshold is indicated by the size of the circle. Unfilled
circles indicate cryptic alleles. The model [linear regression (LR) or Cox’s proportional hazards (CPH)] in which a marker was found to be associated
with Marek’s disease resistance is indicated by the location of the circle on the left or right side of the chromosome, respectively. Asterisks (*)
indicate markers exceeding probability of false positives or false discovery rate threshold of 0.2. Arrows indicate approximate positions of markers
on chromosomes 2,5, and Z with comparison-wise P ≥ 0.1 for both analyses (not all position numbers shown).
in MD resistance between the 2 lines. However, favorable
QTL alleles were also identified as originating from the
less resistant line (i.e., cryptic alleles).
MHC
The MHC has been shown to be associated with resis-
tance to many diseases in poultry, including MD (Bacon
et al., 1981; Bacon, 1987; Steadham et al., 1987; Lamont,
1989, 1998; Bacon and Witter, 1994; Lakshmanan et al.,
1997). The current study did not, however, find an associ-
ation between the MHC and MD survival. In the current
study, the MHC-associated blood group alleles present
were B2 and B15, and the blood group genotypes in the
backcross offspring were B2/B2 or B2/B15. If, for the ex-
perimental population in the current study, the B2 allele
was completely dominant over the B15 allele, a difference
in survival between the 2 MHC genotypes would not be
expected. Epistatic interactions between the MHC and
background genes that were not linked to a marker used
in this study, which could mask an MHC effect, might
also explain the lack of association between blood group
alleles and MD survival. The strain of the MD virus used
in the current study (vv+ 648A) might have also affected
the role of the MHC for affecting survival.
Significance Tests
To account for multiple testing, FDR and PFP thresh-
olds were used. Seven and 6 markers, repectively, ex-
ceeded FDR and PFP threshold of 0.2 using linear regres-
sion and 5 and 5, respectively, using the CPH model. For
PFP, a threshold of 0.2 results in the expectation that 80%
of the tests exceeding this threshold are true positives
(Fernando et al., 2004). Interpretation of a 0.2 threshold
for FDR is more difficult to define but is similar, although
somewhat more conservative, depending on the number
of true effects present in the dataset.
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Another issue to consider regarding experiment-wise
thresholds is that 56 of the markers used in the current
study were selected from previous analyses of DNA pools
for 117 markers on the same experimental population.
Reported results assumed that the 56 markers represented
a random set of markers, regardless of the early pools
results (i.e., on the assumption that the pooling analyses
were not at all indicative of the results of the current
analyses). If the pooling analyses were highly predictive
of results of the current study, all 117 markers used in
the pooling analyses would need to be considered when
determining experiment-wise significance levels using
FDR and PFP, resulting in only 3 markers exceeding the
0.2 threshold (the same 3 markers would exceed the FDR
and PFP threshold of 0.2 for the CPH and linear models).
This, along with the results reported, represents the 2
extremes (i.e., the upper and lower bounds of the experi-
ment-wise thresholds to be used in the current study). A
comparison of CWER probability values from individual
genotyping for the 56 markers that were selected based
on the pools, however, showed rather low correlations,
ranging from 0.11 to 0.21, with probability values from
the pooling analyses, in which the pools were created
within B blood group genotype. This finding indicates
that statistical tests based on the pooling analyses were
not very predictive of the results of statistical tests based
on individual genotyping, and, therefore, our assumption
was correct and the experiment-wise thresholds need not
be corrected for preselection of markers from the pooling
analysis. Note that the problem of preselection does not
arise for the 25 markers selected based on pool analyses
of the reciprocal backcross because these were based on
different individuals and data.
The large discrepancy between results of the statistical
tests from the pooling analysis and the selective genotyp-
ing analysis are likely due to several reasons, including
accuracy of the pools and differences in traits considered
and in methods for statistical analyses. Although the cor-
relation between frequencies of alleles estimated from
pools and the actual frequency of alleles in the individuals
that contributed to the pools was high (approximately
0.90), it was not 1.00, and parental lines were not fixed
for alternate alleles for 44 of the 117 markers, which could
lead to errors from the pooling analyses. The trait ana-
lyzed in pooling analyses was also different from the
trait analyzed in selective genotyping analyses. For the
pooling analyses, pools were formed within blood group
genotype, and the number of tumors was considered as an
additional variable when selecting individuals, whereas
only length of survival was considered as the phenotype
in the current analyses. In addition, individuals that did
not have tumors and that survived to the end of the
study were not included in the pooling analysis but were
included in the selective genotyping analysis. Because
these individuals were the most extreme, they were likely
the most informative in the selective genotyping study
and, therefore, contributed to the discrepancy between
the pooling and individual genotyping analyses. Finally,
the statistical models used for pool analysis and those
used for analysis of the individual genotyping results
were also quite different.
Implications
Identification of and subsequent selection upon QTL
affecting MD resistance will be useful to the poultry in-
dustry to reduce losses caused by MD virus infection
(Vallejo et al., 1998). Improving genetic resistance to MD
can also improve vaccine efficacy (Lamont et al., 2002)
and possibly increase the length of time that vaccines are
useful before the virus mutates to become resistant. The
QTL identified in the current experiment are starting
points for more intensive studies to precisely locate the
QTL positions for utilization in marker-assisted selection
or for identification of the genes responsible for pheno-
typic variation. Phenotypic selection for MD requires ex-
posure and costly challenge of relatives of selection candi-
dates with the pathogenic agent to obtain phenotypic data
on resistance or susceptibility (Arthur and Albers, 2003).
Direct selection on genes that affect resistance to MD,
or on linked markers, does not require a direct disease
challenge of immediate relatives, although challenge
studies are needed to identify initial associations. Direct
selection uses genetic information on selection candidates
rather than their relatives and can be implemented almost
immediately upon hatching, thereby potentially shorten-
ing the generation interval. Therefore, identification of
genetic regions affecting MD resistance is of great value
to the poultry industry. The current study is the first
reported QTL scan for MD resistance in commercial lay-
ers. However, the identification of the QTL on chromo-
some 2 in both the current study and in studies using
experimental lines also shows the usefulness of experi-
mental populations in identifying QTL that may also be
segregating in commercial populations. Current availabil-
ity of the draft of the complete chicken genome sequence
and a 2.8 million single nucleotide polymorphism map
will facilitate future QTL and causative gene identifica-
tion (Hillier et al., 2004; Wong et al., 2004).
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APPENDIX
The hazard function h(t) for a line is proportional to
the conditional probability that an animal dies shortly
after time t given that it survives to time t. The CPH
model assumes that at any time t the hazard resulting
from inheriting the line 1 allele
h(t) = eβh0(t)
is proportional to a baseline hazard h0(t) for inheriting
the line 2 allele. At any time point t, the regression coeffi-
cient β is the natural logarithm of the relative risk that a
death occurs shortly after time t for animals inheriting
the line 1 allele versus those inheriting the line 2 allele,
provided that the animals have survived through time
t. When there is uncertainty about the allele that was
inherited, the hazard is an average of the hazards for the
2 possible alleles h0(t)
h(t) = p(L1)eβh0(t) + [1 − p(L1)]h0(t)
where p(L1) is the probability of inheriting the line 1 allele.
Then, a maximum partial likelihood estimator for β is
obtained by maximizing
Π
r
i=1

p(L1)iexp(β) + [1 − p(L1)i]
∑
jχR(ti)
(p(L1)jexp(β) + [1 − p(L1)j])
 [A1]
where r is the number of observed deaths, and R(ti) de-
notes the set of animals still alive at the time of death i.
This is not a standard form of the Cox partial likelihood,
and it cannot be maximized with standard statistical soft-
ware. To use standard statistical software for the Cox
model, an alternative estimator is obtained by using p(L1)i
as an explanatory variable in a standard Cox model.
This yields
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h(ti) = exp(βp(L1)i)h0(ti)
as an approximation for
h(ti) = [p(L1)iexp(β) + 1 − p(L1)i]h0(t)
resulting in a partial likelihood
Π
r
i=1

exp(βp(L1)i)
∑
jχR(ti)
(exp(p(L1)j(β))
 [A2]
that can be maximized with standard statistical software
for the Cox model. By using simulation, it can be shown
that maximizing [A2] provides an estimator of β that
tends to be biased a little further away from zero than
the estimator obtained by maximizing [A1]. The standard
error for this estimator, however, is also slightly larger,
resulting in a test of significance that maintains nearly
the correct type I error level. Note that maximizing either
[A1] or [A2] results in an increasingly more biased esti-
mate of β as fewer animals with intermediate failure times
are genotyped. When the null hypothesis is true (β = 0),
however, standard errors of the estimators increase in a
proportional manner so tests retain desired type I error
levels.
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